170 related articles for article (PubMed ID: 22130626)
1. A formal [3+3]-annulation-based approach to pancratistatins: total synthesis of (±)-7-deoxy-pancratistatin and its 2-epi and 2,4-diepi analogues.
Nieto-García O; Lago-Santomé H; Cagide-Fagín F; Ortiz-Lara JC; Alonso R
Org Biomol Chem; 2012 Jan; 10(4):825-34. PubMed ID: 22130626
[TBL] [Abstract][Full Text] [Related]
2. Cyclotrimerization strategy toward analogues of amaryllidaceae constituents. synthesis of deoxygenated pancratistatin core.
Moser M; Sun X; Hudlicky T
Org Lett; 2005 Dec; 7(25):5669-72. PubMed ID: 16321018
[TBL] [Abstract][Full Text] [Related]
3. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids.
McNulty J; Nair JJ; Codina C; Bastida J; Pandey S; Gerasimoff J; Griffin C
Phytochemistry; 2007 Apr; 68(7):1068-74. PubMed ID: 17331551
[TBL] [Abstract][Full Text] [Related]
4. Sodium pancratistatin 3,4-o-cyclic phosphate, a water-soluble synthetic derivative of pancratistatin, is highly effective in a human colon tumor model.
Shnyder SD; Cooper PA; Millington NJ; Gill JH; Bibby MC
J Nat Prod; 2008 Mar; 71(3):321-4. PubMed ID: 18154271
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives.
Ghavre M; Froese J; Pour M; Hudlicky T
Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844
[TBL] [Abstract][Full Text] [Related]
6. synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues.
McNulty J; Nair JJ; Griffin C; Pandey S
J Nat Prod; 2008 Mar; 71(3):357-63. PubMed ID: 18225861
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic agents of the crinane series of amaryllidaceae alkaloids.
Nair JJ; Bastida J; Viladomat F; van Staden J
Nat Prod Commun; 2012 Dec; 7(12):1677-88. PubMed ID: 23413581
[TBL] [Abstract][Full Text] [Related]
8. Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore.
McNulty J; Mao J; Gibe R; Mo R; Wolf S; Pettit GR; Herald DL; Boyd MR
Bioorg Med Chem Lett; 2001 Jan; 11(2):169-72. PubMed ID: 11206451
[TBL] [Abstract][Full Text] [Related]
9. A beta-carboline-1-one mimic of the anticancer Amaryllidaceae constituent pancratistatin: synthesis and biological evaluation.
Rinner U; Hudlicky T; Gordon H; Pettit GR
Angew Chem Int Ed Engl; 2004 Oct; 43(40):5342-6. PubMed ID: 15468184
[No Abstract] [Full Text] [Related]
10. Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae.
Nair JJ; Rárová L; Strnad M; Bastida J; van Staden J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6195-9. PubMed ID: 22921081
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of some structural modifications of pancratistatin.
Rinner U; Hillebrenner HL; Adams DR; Hudlicky T; Pettit GR
Bioorg Med Chem Lett; 2004 Jun; 14(11):2911-5. PubMed ID: 15125958
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of structurally simplified analogues of pancratistatin: truncation of the cyclitol ring.
Manpadi M; Kireev AS; Magedov IV; Altig J; Tongwa P; Antipin MY; Evidente A; van Otterlo WA; Kornienko A
J Org Chem; 2009 Sep; 74(18):7122-31. PubMed ID: 19743883
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation.
Vshyvenko S; Scattolon J; Hudlicky T; Romero AE; Kornienko A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4750-2. PubMed ID: 21757350
[TBL] [Abstract][Full Text] [Related]
14. Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine.
Collins J; Rinner U; Moser M; Hudlicky T; Ghiviriga I; Romero AE; Kornienko A; Ma D; Griffin C; Pandey S
J Org Chem; 2010 May; 75(9):3069-84. PubMed ID: 20373760
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of aromatic analogues of conduritol F, L-chiro-inositol, and dihydroconduritol F structurally related to the amaryllidaceae anticancer constituents.
Kireev AS; Nadein ON; Agustin VJ; Bush NE; Evidente A; Manpadi M; Ogasawara MA; Rastogi SK; Rogelj S; Shors ST; Kornienko A
J Org Chem; 2006 Jul; 71(15):5694-707. PubMed ID: 16839151
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs.
McNulty J; Nair JJ; Singh M; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2010 Apr; 20(7):2335-9. PubMed ID: 20189386
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.
Pettit GR; Orr B; Ducki S
Anticancer Drug Des; 2000 Dec; 15(6):389-95. PubMed ID: 11716431
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective synthesis of protected nitrocyclohexitols with five stereocenters. Total synthesis of (+)-pancratistatin.
Cagide-Fagín F; Nieto-García O; Lago-Santomé H; Alonso R
J Org Chem; 2012 Dec; 77(24):11377-82. PubMed ID: 23176756
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic agents. 527. Synthesis of 7-deoxynarcistatin, 7-deoxy-trans-dihydronarcistatin, and trans-dihydronarcistatin 1(1).
Pettit GR; Melody N
J Nat Prod; 2005 Feb; 68(2):207-11. PubMed ID: 15730244
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies on seco-pancratistatin analogs: potent inhibitors of human cytochrome P450 3A4.
McNulty J; Nair JJ; Singh M; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2009 Oct; 19(19):5607-12. PubMed ID: 19713107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
